U.S. DOD/CDMRP: Neurofibromatosis Research Program – LOI

*Clinical Trial Award - Supports research with the potential to have a major impact on the treatment or management of NF. Funds Phase 0, I, or II clinical trials relevant to NF and/or schwannomatosis. Funding: $900K over 4 years.

*Exploration - Hypothesis Development Award - Supports the initial exploration of innovative, high-risk, high-gain groundbreaking concepts. Funding: up to $100K over 2 years.

*Investigator-Initiated Research Award - Supports highly rigorous, high-impact research with the potential to make an important contribution to NF research and/or patient care.. Funding: $525K over 3 years.

*New Investigator Award - Supports the development of promising independent investigators and/or the transition of established investigators from other research fields into a career in NF research. Funding: $450K over 3 years.

https://ebrap.org/eBRAP/public/Program.htm